{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:01:16Z","timestamp":1793721676029,"version":"4.6.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:26:46Z","timestamp":1765366006000},"page":"478-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cyclosporine A in the treatment of dry eye syndrome in patients with Sj\u00f6gren\u2019s disease\u2014a systematic review"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9583-7628","authenticated-orcid":false,"given":"Jarryl H.J.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-0318","authenticated-orcid":false,"given":"Jonathan T.W.","family":"Au Eong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-8925","authenticated-orcid":false,"given":"Kah-Guan","family":"Au Eong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ero.2025.11.006_bib0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.ero.2025.11.006_bib0002","series-title":"Sjogren syndrome [Internet]","author":"Carsons","year":"2025"},{"issue":"1","key":"10.1016\/j.ero.2025.11.006_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40495-025-00393-3","article-title":"Efficacy and safety of topical cyclosporine A in moderate-to-severe dry eye disease: an updated systematic review with meta-analysis","volume":"11","author":"Eng","year":"2025","journal-title":"Curr Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.ero.2025.11.006_bib0004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis","volume":"13","author":"Wan","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ero.2025.11.006_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DDDT.S207743","article-title":"An updated systematic review with meta-analysis of randomized trials on topical cyclosporin A for dry-eye disease","volume":"14","author":"Tuan","year":"2020","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.ero.2025.11.006_bib0006","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ero.2025.11.006_bib0007","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.45.9.732","article-title":"Cyclosporin A (CyA) in primary Sj\u00f6gren\u2019s syndrome: a double blind study","volume":"45","author":"Drosos","year":"1986","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ero.2025.11.006_bib0008","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sj\u00f6gren\u2019s syndrome","volume":"72","author":"G\u00fcnd\u00fcz","year":"1994","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ero.2025.11.006_bib0009","first-page":"85","article-title":"Topical cyclosporine therapy for keratoconjunctivitis sicca in Sj\u00f6grens\u2019 syndrome","volume":"15","author":"Fan","year":"2003","journal-title":"Tzu Chi Med J"},{"issue":"8","key":"10.1016\/j.ero.2025.11.006_bib0010","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1080\/09273948.2022.2094812","article-title":"Evaluation of the efficacy and safety of topical 0.05% cyclosporine eye drops (II) in the treatment of dry eye associated with primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Gao","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ero.2025.11.006_bib0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/ICO.0000000000002148","article-title":"Efficacy of the fluorescein tear breakup time test in dry eye","volume":"39","author":"Paugh","year":"2020","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ero.2025.11.006_bib0012","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clae.2013.07.008","article-title":"Rose Bengal staining as an assessment of ocular surface damage and recovery in dry eye disease-a review","volume":"36","author":"Doughty","year":"2013","journal-title":"Cont Lens Anterior Eye"},{"issue":"5","key":"10.1016\/j.ero.2025.11.006_bib0013","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ero.2025.11.006_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ero.2025.11.006_bib0015","article-title":"Topical cyclosporine A therapy for dry eye syndrome","volume":"9","author":"de Paiva","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ero.2025.11.006_bib0016","series-title":"Cyclosporine [Internet]","author":"Tapia","year":"2025"},{"issue":"3","key":"10.1016\/j.ero.2025.11.006_bib0017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.0022-202x.2001.01452.x","article-title":"Cyclosporin A promotes hair epithelial cell proliferation and modulates protein kinase C expression and translocation in hair epithelial cells","volume":"117","author":"Takahashi","year":"2001","journal-title":"J Invest Dermatol"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:12:02Z","timestamp":1766005922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S3050708125001065"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.006","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine A in the treatment of dry eye syndrome in patients with Sj\u00f6gren\u2019s disease\u2014a systematic review","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}